Pharmaceuticals
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
64 Fifer Ln, Lexington, Massachusetts, 0...Phone Number
(781) 652-8210Website
www.pepducin.comRevenue
$8.7 MillionIndustry
ZI Rank: 1
About Pharmaceuticals
Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pharmaceuticals
Earning: See what the market has to say on Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Pharmaceuticals has new funding data
Product Launch: Get notified when Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Pharmaceuticals Tech Stack
A closer look at the technologies used by Pharmaceuticals
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Pharmaceuticals
Oasis Pharmaceuticals, LLC is a privately funded start-up focused on developing therapeutic treatments for diseases such as MASH, IPF, and Atopic Dermatitis through its innovative Pepducin Technology. The company aims to enhance patient health by targeting G-protein coupled receptors, specifically Protease-activated Receptor 2 (PAR2), along with ot... Read More
